Early research (Phase 1)Study completedNCT01056874What this trial is testingEffect Of Maraviroc On The Pharmacokinetics Of DigoxinWho this might be right forHealthyHIV Infections ViiV Healthcare 12
Testing effectiveness (Phase 2)UnknownNCT00299897What this trial is testingSP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV PatientsWho this might be right forHIV InfectionsHuman Immunodeficiency Virus Samaritan Pharmaceuticals, Inc 60
Large-scale testing (Phase 3)Study completedNCT01939197What this trial is testingA Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 CoinfectionWho this might be right forHepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more AbbVie 318
Not applicableLooking for participantsNCT07226323What this trial is testingTesting the WeCare Intervention to Address Mental Health and Medication Adherence Challenges Among MSM in South AfricaWho this might be right forHIV InfectionsMental Health Emory University 60
Not applicableStudy completedNCT02626286What this trial is testingFeasibility and Interest of a HIV Quarterly Preventive Global Care in Men Who Have Sex With Men in Sub-Saharan AfricaWho this might be right forHIV Infection ANRS, Emerging Infectious Diseases 885
Testing effectiveness (Phase 2)UnknownNCT00131560What this trial is testingSafety and Efficacy of T Cell Genetic Immunotherapy for HIVWho this might be right forHIV Infection VIRxSYS Corporation 60
Not applicableUnknownNCT05140603What this trial is testingAmbispective Cohort Study to Evaluate the Efficacy, Safety, and Tolerance of an Antiretroviral Regimen With DoravirineWho this might be right forHiv Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 150
Testing effectiveness (Phase 2)Study completedNCT00002003What this trial is testingPhase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic LymphomasWho this might be right forLymphoma, Non-HodgkinHIV Infections Lederle Laboratories
Not applicableStudy completedNCT05371327What this trial is testingCommunity Solutions to Adolescent Research Consent - Minor Consent for Biomedical HIV ResearchWho this might be right forInformed ConsentHIV Infections Indiana University 128
Early research (Phase 1)Study completedNCT00002373What this trial is testingThe Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected PatientsWho this might be right forCytomegalovirus InfectionsHIV Infections Glaxo Wellcome 56
Not applicableLooking for participantsNCT06778083What this trial is testingSTI Prophylaxis and Emergence of Antimicrobial ResistanceWho this might be right forSexually Transmitted Infection (STI) PreventionAntibiotic ProphylaxisAntibiotic Resistance, Bacterial+2 more University College, London 108
Large-scale testing (Phase 3)Study completedNCT02660905What this trial is testingHIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-InfectionWho this might be right forHuman Immunodeficiency VirusHepatitis C, Chronic Ottawa Hospital Research Institute 25
Not applicableStudy completedNCT01048671What this trial is testingManagement of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)Who this might be right forHIV Infections Merck Sharp & Dohme LLC 482
Testing effectiveness (Phase 2)Study completedNCT00333684What this trial is testingSafety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-AlcamidWho this might be right forHuman Immunodeficiency VirusFacial Lipoatrophy Canadian Immunodeficiency Research Collaborative 36
Not applicableStudy completedNCT01413152What this trial is testingResidual Risk Assessment Of HIV TransmissionWho this might be right forHIV Infection French National Agency for Research on AIDS and Viral Hepatitis 167
Not applicableStudy completedNCT00006444What this trial is testingThe Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected WomenWho this might be right forHIV InfectionsPapilloma National Institute of Allergy and Infectious Diseases (NIAID) 160
Testing effectiveness (Phase 2)Study completedNCT00035893What this trial is testingThe Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAARTWho this might be right forHIV SeropositivityHIV Infection AIM ImmunoTech Inc. 40
Testing effectiveness (Phase 2)Study completedNCT00008463What this trial is testingA Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)Who this might be right forHIV InfectionsHepatitis C National Institute of Allergy and Infectious Diseases (NIAID) 132
Early research (Phase 1)Study completedNCT00001133What this trial is testingSafety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or SaquinavirWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableStudy completedNCT01020552What this trial is testingIntegrating Family Planning Into Postabortion CareWho this might be right forPostabortion Care FHI 360 300